January 22, 2010 – 10:05 am
by Steven Niles Up-to-date contact information for healthcare professionals and prescribers is critical asset to life sciences companies. CRM provider Cegedim Dendrite serves that need via its OneKey Services, a customer data management and integration solution. With the recent acquisition of U.S. healthcare data provider SK&A Information Services Inc., Cegedim Dendrite executives hope to strengthen that offering.
OneKey is [...]
Tags: Cegedim Dendrite, data management, OneKey, SK&A
Posted in
Pharma Business, Technology |
No Comments »
January 19, 2010 – 5:07 pm
by Steven Niles A 9-year-old boy obsesses over his mayoral approval rating within the online world of Sim City 2000. A 13-year-old girl misses dinner to attend a board meeting as her World of Warcraft compatriots debate the merits of a guild merger. Speaking today at a panel discussion hosted by ProtonMedia and Microsoft, Melanie Kittrell, director, e-business strategy and solutions, Merck & Co., offered these two examples from her own life to illustrate how the kids of today are developing surprising business acumen without even knowing it through their game play in virtual environments.
Tags: business, collaboration, education, learning, medical education, Microsoft, ProtonMedia, sales force, virtual environment
Posted in
Economy, Pharma Business, Pharmaceutical operations, Professional education, Sales force effectiveness, Technology, e-Marketing |
3 Comments »
January 13, 2010 – 5:10 pm
by Joshua Slatko So-called “pay for delay” deals, the arrangements in which pharmaceutical companies pay off potential generic competitors in exchange for a delayed generic launch, have been a popular target of industry critics for years. But now such deals may be in mortal danger. Speaking at a joint press conference today, FTC chairman Jon Leibowitz (who has [...]
Posted in
Uncategorized |
1 Comment »
January 13, 2010 – 2:47 pm
by Steven Niles As J.P. Morgan’s 28th Annual Healthcare Conference in San Francisco winds down, Kevin Butler of Heritage Partners International checks in with one final report.
Although there is guarded optimism all around, Mr. Butler believes that we can expect any shock to the system to cause major trauma. “Perhaps if ee get through the next several months [...]
Tags: deal making, healthcare conference, Heritage Partners, J.P. Morgan
Posted in
Pharma Business, Pharmaceutical operations |
1 Comment »
January 12, 2010 – 4:25 pm
by Steven Niles Kevin Butler of Heritage Partners International has reported in with his Tuesday afternoon update from J.P. Morgan’s 28th Annual Healthcare Conference in San Francisco.
In his previous update, Mr. Butler reported good spirits among the attendees. However, there seems to be an East Coast/West Coast divide.
“The West Coast people seem much less upbeat while the East [...]
Tags: deal making, healthcare conference, Heritage Partners, J.P. Morgan
Posted in
Pharma Business, Pharmaceutical operations |
1 Comment »
January 12, 2010 – 11:10 am
by Steven Niles Frequent Med Ad News contributor Kevin Butler of Heritage Partners International is in attendance at J.P. Morgan’s 28th Annual Healthcare Conference in San Francisco. Mr. Butler will be checking in routinely with updates from the event, which brings together industry leaders and technology and service providers.
Upon arriving yesterday, January 11, Mr. Butler reported that the [...]
Tags: deal making, healthcare conference, Heritage Partners, J.P. Morgan
Posted in
Pharma Business, Pharmaceutical operations |
1 Comment »
January 11, 2010 – 6:02 pm
by Chris As the value of electronic medical records/electronic health records continues to be debated, some would say the pharmaceutical industry needs to take a visible, positive stand on that issue. But the crowd who attended a thought leader panel discussion in December, “EMRgency Medicine – Are you Ready,” held by the American College of Healthcare Executives [...]
Tags: EMR, healthcare, pharma
Posted in
Uncategorized |
1 Comment »
January 7, 2010 – 12:22 pm
by Gina Monari Four McCann Healthcare Worldwide executives will be shouldering the responsibilities of a newly created Office of the CEO in the wake of CEO Richard Nordstrom’s departure. Mr. Nordstrom is leaving the position he has served in since 2005 to take on new initiatives, which are expected to be announced at a future date, and his position will not be refilled [...].
Posted in
Uncategorized |
No Comments »
December 22, 2009 – 2:29 pm
by Gina Monari Chronic conditions, such as those within the autoimmune therapeutic category, are being made more manageable by new devices that make home administration more convenient, dosing more effective, and improve patient compliance. Industry predictions are that therapies for treating those patients will continue to be launched with some form of autoinjector technologies [...].
Posted in
Patient education, Professional education, Technology |
2 Comments »
December 21, 2009 – 2:50 pm
by Steven Niles Healthcare reform has taken a major step forward as the Democratic caucus voted to curtail debate on the bill. The final vote on the Senate’s version of healthcare reform could come by Christmas, at which point the Senate must then draft a compromise with the House, which approved its own bill Nov. 7.
As we don’t [...]
Tags: healthcare reform
Posted in
Legal actions, Pharma Business, Pharmaceutical operations, Sales & Marketing |
1 Comment »
|
